Schonfeld Strategic Advisors LLC

Position in CRBU — Caribou Biosciences, Inc.

CIK 1665241 NEW YORK, NY

Position in CRBU

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$45,541

-$1,255,941 QoQ

Shares Held

23,969

-95.7% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#76

of 137 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $295,816,121 across 125 Biotechnology names. CRBU ranks #111 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,757,899	$25,419,219
2	ALNY	Alnylam Pharmaceuticals, Inc.	71,767	$23,745,547
3	PTCT	Ptc Therapeutics, Inc.	318,405	$21,692,932
4	XENE	Xenon Pharmaceuticals Inc.	324,722	$18,882,584
5	INBX	Inhibrx Biosciences, Inc.	254,827	$17,132,019
6	JAZZ	Jazz Pharmaceuticals plc	62,142	$11,747,945
7	RARE	Ultragenyx Pharmaceutical Inc.	494,737	$10,364,740
8	INSM	INSMED Inc	56,056	$9,166,277

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$45,541	23,969	-95.7%	Shares	Sole	2026-05-15
2025-09-30	$1,301,482	558,576	-75.4%	Shares	Sole	2025-11-14
2025-06-30	$2,863,811	2,272,866	-3.3%	Shares	Sole	2025-08-14
2025-03-31	$2,146,994	2,351,582	+11.3%	Shares	Sole	2025-05-15
2024-12-31	$3,360,102	2,113,272	+28.4%	Shares	Sole	2025-02-14
2024-09-30	$3,225,246	1,645,534	+84.5%	Shares	Sole	2024-11-14
2024-06-30	$1,462,643	891,856	-51.6%	Shares	Sole	2024-08-14
2024-03-31	$9,472,577	1,842,914	+11910.6%	Shares	Sole	2024-05-15
2022-09-30	$161,879	15,344	+31.1%	Shares	Sole	2022-11-14
2022-06-30	$63,531	11,700	-20.9%	Shares	Sole	2022-08-15
2022-03-31	$135,864	14,800	+41.0%	Shares	Sole	2022-05-16
2021-09-30	$250,635	10,500	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.